Pre-TAVR Revascularization: Angiographic or Physiological?

In patients undergoing transcatheter aortic valve replacement (TAVR), fractional flow reserve (FFR) guided revascularization is associated with favorable results compared against the traditional angiography guided revascularization. 

Debemos tener en cuenta a la isquemia crítica de MM II en el TAVI

Given the complete lack of randomized studies, this observational study is the best we have to decide how to guide revascularization in patients with symptomatic severe aortic stenosis undergoing TAVR. 

The current trend clearly favors the conservative revascularization strategy that treats only proximal lesions as opposed to what we used to do some time ago, treating as many lesions as possible seeing as accessing the coronary arteries post implant might get harder. 

All patients with severe aortic stenosis and coronary artery disease by angiography were included in this retrospective analysis and were divided into two groups: angiography (122/216; 56.5%) vs FFR (94/216; 43.5%) guided TAVR. Patients were followed up at 2 years to assess major events rate. 


Read also: AHA 2019 | COMPLETE: Complete Revascularization Is Superior since It Treats Other Vulnerable Plaque.


Most of the lesions (78.2%) assessed with FFR resulted negative for ischemia according to the standard cutoff value of 0.80 and were therefore deferred.

The FFR guided group presented a higher event-free survival rate vs. the angiography group (92.6% versus 82.0%; HR, 0.4; CI 95%, 0.2–1.0; p=0.035).


Read also: AHA 2019 | Treat Stroke to Target: Post-Stroke Aggressive Therapy with Statins.


Patients whose lesions were deferred also presented a higher event-free survival rate than the angiography group (91.4% versus 68.1%; HR, 0.3; CI 95% 0.1–0.6; p=0.001), which is why it seems safe to defer lesions based on FFR in this understudied particular population.

Conclusion

FFR guided revascularization in patients with coronary lesions and severe aortic stenosis undergoing TAVR resulted favorable vs. angiography guided revascularization. 

Original Title: Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation.

Reference: Mattia Lunardi et al. J Am Heart Assoc. 2019; 8:e012618.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...